Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

GlaxoSmithKline expands Canadian manufacturing plant

June 20, 2011
Manufacturing and Production GSK, pharma manufacturing news

GlaxoSmithKline has set aside almost £19 million ($31 million) to expand a manufacturing facility in Ontario, Canada, creating 70 additional …

News

GSK takes control of China vaccines venture

June 15, 2011
Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, Shenzhen Neptunus Interlong Bio-Technique Co, vaccines

GlaxoSmithKline is increasing its footprint in China, shelling out £24 million ($39 million) to buy the remaining stake in a …

News

Arecor and GSK collaborate on vaccine technology

June 15, 2011
Manufacturing and Production, Research and Development Arecor, GSK, vaccines

GSK is to team up with UK company Arecor to develop advanced formulations of GSK’s vaccines. Cambridge-based Arecor has developed …

News
GlaxoSmithKline

GSK’s epilepsy treatment Potiga wins US approval

June 13, 2011
Sales and Marketing GSK, Potiga, Trobalt, Valeant, epilepsy

The FDA has approved GlaxoSmithKline and Valeant’s epilepsy treatment Potiga, but the drug will require further review before it can …

News

GSK and Merck cut vaccine prices

June 6, 2011
Sales and Marketing Bill and Melinda Gates Foundation, GSK, Merck & Co, developing world, vaccines

GlaxoSmithKline and Merck & Co have pledged to offer their rotavirus vaccines at discounted prices to developing countries. GSK is …

News
GlaxoSmithKline

GSK sales suffer double-digit drop

April 28, 2011
Sales and Marketing GSK, GlaxoSmithKline

GlaxoSmithKline saw a hefty drop in revenue in the first three months of this year as it struggled to contend …

News

GlaxoSmithKline OTC sale puts two plants on the block

April 19, 2011
Manufacturing and Production GSK, US, pharma manufacturing

GlaxoSmithKline’s decision to sell off a swathe of over-the-counter medicines means that a manufacturing facility in Memphis, Tennessee, has been …

News

GlaxoSmithKline to drop Alli and other OTC products

April 15, 2011
Research and Development, Sales and Marketing Alli, GSK, OTC, Tyverb

GlaxoSmithKline is to sell off its weight loss drug Alli and other less profitable non-prescription drugs. GSK announced its decision …

News

GSK pilots wireless sensors to improve plant efficiency

April 11, 2011
Manufacturing and Production API, GSK, Ireland

GlaxoSmithKline has started pilot testing of a wireless system of flow and pressure transmitters to try to improve the efficiency …

News

GSK and Valeant’s epilepsy treatment approved

April 8, 2011
Sales and Marketing GSK, Trobalt, Valeant, epilepsy

The European Commission has granted marketing authorisation for Trobalt, the new epilepsy drug from GSK and Valeant. Trobalt (retigabine) has …

News
GlaxoSmitKline

GSK details $28.5m of research payments to US institutions

April 1, 2011
Research and Development GSK, payments

GlaxoSmithKline has made public the payments it gave last year to US institutions engaged in clinical research on its behalf. …

News

GSK withdraws applications for Avodart

March 25, 2011
Research and Development Avodart, Cancer, GSK, bph, prostate cancer

GlaxoSmithKline has withdrawn all regulatory applications for Avodart to prevent prostate cancer after regulators raised doubts about its benefit/risk profile. …

News
GlaxoSmithKline office

GSK to fund schools science programme

March 23, 2011
Research and Development, Sales and Marketing GSK, GlaxoSmithKline, King's College, school science

GlaxoSmithKline has followed its pledge to refund the tuition fees of UK graduates it takes on with a less direct …

News

GSK Parkinson’s drug impresses at phase III

March 21, 2011
Research and Development ADVANCE-PD, GSK, GlaxoSmithKline, IPX066, Impax Pharmaceuticals, Parkinson's disease, Parkinson’s disease

GlaxoSmithKline’s advanced Parkinson’s disease drug IPX066 has impressed in a head to head trial against it nearest rival. The phase …

News

GSK in manufacturing research collaboration with university

March 18, 2011
Manufacturing and Production Advanced Manufacturing, Centre for Innovative Manufacturing in Emergent Macromolecular Therapies, EPSRC fund, GSK, GlaxoSmithKline, Manufacturing Fellowships, academic research, pharma manufacturing

Research into a cutting-edge area of pharmaceutical manufacturing in the UK is to be supported by a new £51 million …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025